Navigation Links
Drug Safety Firm BioSoteria Receives 2009 Best of Business Award
Date:3/25/2010

BioSoteria been selected for the 2009 Best of Business Award in the Commercial Site category by the Small Business Commerce Association (SBCA). The SBCA 2009 Award Program recognizes the top 5% of small businesses throughout the country, identified through statistical research and monthly surveys.

Emeryville, CA (PRWEB) March 25, 2010 -- BioSoteria, Inc., a drug safety services and education firm, announced today that it has been selected for the 2009 Best of Business Award in the Commercial Site category by the Small Business Commerce Association (SBCA).

The SBCA 2009 Award Program recognizes the top 5% of small businesses throughout the country. Using statistical research and information taken from monthly surveys, the SBCA identifies companies that it believes has demonstrated what makes small businesses a vital part of the American economy. Award winners are a valuable asset to their community and exemplify what makes small businesses great.

“I founded BioSoteria in 2007 to provide drug safety services to the community of growing biotechnology companies in the San Francisco area,” said Sally Van Doren, President and CEO of BioSoteria. “The Best of Business Award from SBCA recognizes our success as a service provider to not only Bay-area companies, but to biotechnology and pharmaceutical companies across North America and worldwide. We are pleased to receive this recognition.”

About Small Business Commerce Association (SBCA)
Small Business Commerce Association (SBCA) is a private sector entity that aims to provide tactical guidance in many day-to-day issues that small business owners face. In addition to providing a central repository of small business operational advice, SBCA identifies companies that exemplify what makes small business a vital part of the American economy. For more information, visit the website at www.SBCAAwards.org.

About BioSoteria
From strategic risk management consulting services and world-class pharmacovigilance training and education to full-service drug safety department capabilities, BioSoteria provides unmatched experience, expertise and leadership to support pharmaceutical and biotechnology companies’ efforts to maximize the benefit/risk balance of their products. To learn more about BioSoteria, please visit the company’s website at www.biosoteria.com, or call 1-866-660-5553.

###

Read the full story at http://www.prweb.com/releases/drugsafety/pharmacovigilance/prweb3787924.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. American Society of Anesthesiologists: Is Apathy or Avarice Precluding Advocacy of Better Patient Safety?
2. OrbusNeichs Genous(TM) Bio-engineered R stent(TM) Demonstrates Good Safety and Clinical Outcomes in Patients with Primary PCI for STEMI
3. Drug Safety Firm BioSoteria Announces Exponential Growth in 2009
4. RFID tags to boost transit worker safety
5. FDA researchers identify new MRI safety risk for patients with pacemakers
6. Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced
7. S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders
8. Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS
9. BioSoteria CEO to Present at Drug Safety Conference
10. Sanofi Pasteur Presents Safety Data on Menactra(R) Vaccine Given to Infants at Infectious Disease Society Meeting
11. Safety in Drinking Water? Monitoring for Radioactive Contaminants Only Required Every Three, Six, or Nine Years per Federal Law
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Safety Firm BioSoteria Receives 2009 Best of Business Award 
(Date:1/19/2017)... 19, 2017 Research and Markets ... has announced the addition of the ... Forecast to 2025" report to their offering. ... The report provides a detailed analysis on current and future market trends ... using estimated market values as the base numbers Key ...
(Date:1/19/2017)... GAITHERSBURG, Md. , Jan. 19, 2017 /PRNewswire/ ... a privately-held immunotherapeutics company targeting infectious diseases, announced ... the merger of PharmAthene and Altimmune in an ... Fund, HealthCap, Truffle Capital and Redmont Capital. The ... immunotherapeutics company with four clinical stage and one ...
(Date:1/19/2017)... , ... January 18, 2017 , ... ... Institutes of Health (NIH) to update its Data Sharing Policy. Specifically, the nation’s ... of grant applications subject to the existing policy. AMIA recommended that NIH earmark ...
(Date:1/19/2017)... ... 2017 , ... DaVita Clinical Research (DCR), a ... device development, and Prism Clinical Research , a leader in providing fully ... Clinical Trials (VCT) has been selected by both companies as an exclusive ...
Breaking Biology Technology:
(Date:12/20/2016)... 20, 2016 The rising popularity of ... leasing is stoking significant interest in keyless access ... Bluetooth low energy (BLE), biometrics and near-field communication ... wave of wireless technologies in the automotive industry. ... advanced access systems opens the market to specialist ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic Biomedicals ... el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera ... en 2017, con múltiples sitios previstos a lo largo de Europa ... MSC-1 ... factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa ...
(Date:12/16/2016)... DUBLIN , Dec 16, 2016 Research ... Access System Market - Global Forecast to 2021" report to ... ... projected to grow at a CAGR of 14.06% from 2016 to ... 2016, and is projected to reach 854.8 Million by 2021. The ...
Breaking Biology News(10 mins):